OncologyTube Professional - Patients Click Here
741,967 video views
feeds: Videos
05:36
The strategy involves multi-platform technology and the use of specific algorithms to decide which combinations of drugs would best suit a particular patient, he explains in the interview. The aim is to hopefully show regulatory agencies, health authorities and medical insurance companies that th...
by:feeds | 428 views
09:11
At the 9th European Breast Cancer Conference (EBCC), Matti Aapro, MD, of Clinique de Genolier, Genolier, Switzerland, and Daniel Rea, MBBS, BSc, PhD, FRCP, of the University of Birmingham, Birmingham, United Kingdom, UK, discuss the molecular diversity of breast cancer. They explain that patients with breast cancer can be categorised using mole...
by:feeds | 451 views
06:11
In this video Dr. John Leonard discusses the recent findings from a publication in the New England Journal of Medicine about the efficacy of substituting bortezomib for vincristine in R-CHOP could improve the outcomes in patients with newly diagnosed mantle cell lymphoma.Mantle cell lymphoma is an unusual lymphoma that engenders much debate as to w...
by:feeds | 468 views
03:09
In this video, Dr. Peter Martin discusses the implications of a study recently published in Lancet Oncology, which aimed to discover whether a blood test capable of detecting circulating tumor DNA might predict treatment success or failure. In the future, blood tests may be added to, or even replace...
by:feeds | 346 views
04:19
In this video Dr. Jia Ruan explained the results from a randomized phase 3 trial published in JAMA (The Journal of the American Medical Association). In this study researchers compared the effectiveness of Entecavir and lamivudine in preventing HBV reactivation and clinically significant hepatitis i...
by:feeds | 348 views
02:24
The purpose of this study is to evaluate the clinical benefits of nivolumab in people with relapsed Hodgkin Lymphoma. This phase II trial is for men and women with Hodgkin Lymphoma whose disease has relapsed after an autologous stem cell transplant. http://corne... For more informa...
by:feeds | 461 views
12:22
A unique clinical study- The application of vaccine for localized prostate cancer disease. Dr. Israel Barken from the Prostate Cancer Research and Education Foundation More on Prostvac Studies visit AskDrBarken.WordPress.com
by:feeds | 538 views
07:18
Hapreet Singh M.D. discusses a Phase I study approach of priming the immune system with Prostvac vaccination, intensified immunotherapy with Ipilimumab to further enhance the immune response. This was presented by Hapreet Singh M.D. from the National Cancer Institute
by:feeds | 521 views
01:47
CONCLUSIONS: A clinically relevant 30% reduction in risk of progression or death was seen with ELd vs Ld. More pts remain on ELd vs Ld and follow-up for long-term outcomes, including survival, is ongoing. IRs were manageable. Elo, a mAb with a novel immunotherapeut​ic mechanism of action, showed improved PFS, with minimal added toxicity in combinati...
by:feeds | 1314 views
03:56
Dr. Bendell discusses the results of a randomized, double-blind, multicenter phase 2 trial that examined FOLFOX plus or minus ramucirumab as front-line therapy for advanced gastric or esophageal adenocarcinoma. Dr. Bendell, MD, Director of GI Cancer Research Program, associate director, Drug Devel...
by:feeds | 580 views
dsfsd